Related Experiment Videos
Lichen amyloidosus: a new therapeutic approach
Acta Dermato-Venereologica
|January 1, 1985
Summary
Topical dimethyl sulfoxide (DMSO) effectively treated lichen amyloidosus, rapidly reducing itching and papule size. Histological analysis confirmed a partial disappearance of amyloid deposits, showcasing DMSO's therapeutic potential.
Area of Science:
- Dermatology
- Biochemistry
Background:
- Lichen amyloidosus is a chronic pruritic papular skin disease characterized by amyloid deposition in the papillary dermis.
- Current treatment options for lichen amyloidosus are limited and often provide only symptomatic relief.
Observation:
- A single patient with lichen amyloidosus was treated topically with dimethyl sulfoxide (DMSO).
- Clinical assessment was performed to evaluate the efficacy of DMSO treatment.
Findings:
- Topical DMSO treatment resulted in rapid improvement of pruritus within five days.
- Significant flattening of papules was observed within two weeks of therapy.
- Histological examination confirmed partial resolution of amyloid deposits, supporting clinical observations.
Implications:
- Topical DMSO represents a promising therapeutic agent for lichen amyloidosus, offering both symptomatic and potentially disease-modifying effects.
- Further clinical trials are warranted to establish the safety and efficacy of DMSO in a larger cohort of patients with lichen amyloidosus.